Health Care DataWorks Applauds Cedars-Sinai for Attaining HIMSS Analytics Stage 7 Designation

Posted on by

Columbus, OH (PRWEB) March 19, 2014

Health Care DataWorks (HCD) takes great pleasure in congratulating its technology partner, world-renowned academic medical center Cedars-Sinai, for achieving Stage 7 on the HIMSS Analytics EMR Adoption Model (EMRAM). Stage 7 represents an advanced and paperless patient record environment, and is the highest designation awarded by EMRAM.

A leading provider of business intelligence solutions and healthcare analytics, HCD partnered with Cedars-Sinai last year to implement HCDs KnowledgeEdge Enterprise Data Warehouse (EDW) to capture and analyze data. HCDs solution played an important role in Cedar-Sinais use of its data warehouse to generate normalized patient care data and to comply with EMRAM requirements for Stage 7.

Less than three percent of hospitals nationwide have achieved Stage 7, we are proud of our doctors, nurses, and all of our staff who played such a vital role in helping us to be recognized with this honor, said Darren Dworkin, SVP and CIO at Cedars-Sinai. We recognize that HCDs EDW enabled us to reach this high level more quickly than we anticipated. Our use of analytics gives us a competitive and quality advantage as we support the sharing and use of data to improve the delivery of patient care.

HCDs KnowledgeEdge brings together the existing silos of data and unifies them into a data model built specifically for healthcare organizations. Through the use of accelerators such as pre-built dashboards, applications and reports, organizations can quickly empower their users with the data they need for critical decision making. The solution includes all of the software, hardware and services required to implement an EDW in a fraction of the time and cost required to build one.

To reach Stage 7, a hospital or health system must prove they are using data warehousing and mining techniques to effectively capture and analyze data to use in improving their performance, quality of care and patient safety, said Richard Gibson, MD, one of the three surveyors HIMSS Analytics sent to Cedars-Sinai to conduct the Stage 7 survey. In the case of Cedars-Sinai, it was abundantly clear to us that the data warehousing solution they have in place is doing just that.

In Stage 7, the hospital is truly paperless. Clinical information can be readily shared with other hospitals, ambulatory clinics, sub-acute environments, employers, payers and patients via standard electronic transactions.

"Cedars-Sinai has long been a pioneer in health information technology. It is a privilege to partner with the organization in implementing an EDW and contribute to the attainment of this designation, said Jason Buskirk, CEO of HCD. This is a critical time for health IT. Hospitals and other eligible providers have until 2015 to demonstrate meaningful use of certified EMR technology before being penalized. We are pleased that HCD can offer a solution to assist organizations in attaining this goal. We congratulate Cedars-Sinai for joining the exclusive corps of hospitals who have reached Stage 7.

Health Care DataWorks, Inc. Health Care DataWorks, Inc., a leading provider of business intelligence solutions, empowers healthcare organizations to improve their quality of care and reduce costs. Through its pioneering KnowledgeEdge product suite, including its enterprise data model, analytic dashboards, applications, and reports, Health Care DataWorks delivers an Enterprise Data Warehouse essential for hospitals and health systems to effectively and efficiently gain deeper insights into their operations. For more information, visit http://www.hcdataworks.com.

Visit link:

Health Care DataWorks Applauds Cedars-Sinai for Attaining HIMSS Analytics Stage 7 Designation

City health savings disappoint Manchester officials

Posted on by

MANCHESTER City health care costs are on track to exceed the budget for the current fiscal year by $2.3 million, a large shortfall that is raising questions about why union concessions are not resulting in greater savings.

The new projections were reviewed by the aldermens Committee on Accounts on Tuesday.

We were hoping the plan change would save money, said Guy Beloin, the citys assistant finance director.

Beloin told the committee that claims data had to be further analyzed to determine whether the higher than anticipated health costs were being driven by city employees getting more treatment or by higher costs for care.

Beloin noted that health care costs hadnt escalated dramatically; rather the city had budgeted $2 million less for health care in the current fiscal year than the previous year, on the assumption that contract concessions would result in greater savings.

Beloin noted that total claims costs were comparable to what they were in 2012, but that there were 62 more people covered by the city then.

Later on Tuesday, the full Board of Mayor and Aldermen voted to move forward a proposal for the city to hire a $48,000-per-year wellness coordinator who would provide guidance to employees on nutrition, exercise and receiving preventive medical care. The board voted, without discussion, to send the proposal to the Committee on Human Resources.

Under contracts between municipal unions and the city first reached in 2012, city workers have seen their health insurance premiums go up; their office visit co-pays went to $20 from $5. Currently, workers pay 15 percent of their premiums. In the 2013 fiscal year, the city spent $2.4 million less on health care than it did the previous year. This figure, however, was also $1 million higher than projected in that years budget.Following Tuesdays meeting, Mayor Ted Gatsas, who has pushed for the health care concessions, said he and his staff are examining whats causing the higher than expected costs.

Were looking at it now, he said. Theres no real understanding whether its utilization or costs. But I think it settles out if you at where we were last year.

tsiefer@unionleader.com

Original post:

City health savings disappoint Manchester officials

Genetic, Non-Invasive Test Could Improve Colon Cancer Screening

Posted on by

Contact Information

Available for logged-in reporters only

Newswise A non-invasive test that includes detection of the genetic abnormalities related to cancer could significantly improve the effectiveness of colon cancer screening, according to research published by a team of scientists including David Ransohoff, MD, professor of medicine at the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center member. The large-scale, cross-sectional study was published online today in The New England Journal of Medicine.

The study compared two different types of tests used for screening colorectal cancer: a non-invasive, multitarget stool test that includes DNA markers related to colon cancer along with a test that detects stool blood, versus a commercial fecal immunochemical test (FIT). While the FIT test detects hidden blood in the stool, a potential signal for cancer, the multitarget test also includes genetic mutations in the stool that are related to cancer. In the study of nearly 10,000 participants, the DNA test detected 92 percent of colon cancer, significantly more cancers compared to the 72 percent for the FIT test in asymptomatic participants at average risk for colorectal cancer.

The results from this study could impact screening rates, which remain frustratingly low in the U.S. despite the evidence of their effectiveness.

Detection of 92 percent of colon cancer is extremely high for a non-invasive test, so that a negative test result means that no further evaluation, like colonoscopy, is needed at that time, said Ransohoff. Having such a sensitive, non-invasive option could have an important effect on screening rates for colorectal cancer.

While the DNA test appears to be more sensitive than the FIT test, it did produce more false positive results, which would lead to colonoscopy. Further, the study did not address the question of how frequently non-invasive testing might be needed. Colorectal cancer is the third leading cause of cancer-related deaths in the United States and is expected to cause over 50,000 deaths in 2014, according to the American Cancer Society.

In addition to the University of North Carolina, additional institutions involved in the study include Indiana University School of Medicine, Icahn School of Medicine at Mount Sinai, Kaiser Permanente Medical Center, and the Boston Biostatistics Research Foundation. The study was funded by Exact Sciences.

More here:

Genetic, Non-Invasive Test Could Improve Colon Cancer Screening

Genetic test could improve colon cancer screening

Posted on by

PUBLIC RELEASE DATE:

19-Mar-2014

Contact: Katy Jones katy_jones@unc.edu 919-962-3405 University of North Carolina Health Care

A non-invasive test that includes detection of the genetic abnormalities related to cancer could significantly improve the effectiveness of colon cancer screening, according to research published by a team of scientists including David Ransohoff, MD, professor of medicine at the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center member. The large-scale, cross-sectional study was published online today in The New England Journal of Medicine.

The study compared two different types of tests used for screening colorectal cancer: a non-invasive, multitarget stool test that includes DNA markers related to colon cancer along with a test that detects stool blood, versus a commercial fecal immunochemical test (FIT). While the FIT test detects hidden blood in the stool, a potential signal for cancer, the multitarget test also includes genetic mutations in the stool that are related to cancer. In the study of nearly 10,000 participants, the DNA test detected 92 percent of colon cancer, significantly more cancers compared to the 72 percent for the FIT test in asymptomatic participants at average risk for colorectal cancer.

The results from this study could impact screening rates, which remain frustratingly low in the U.S. despite the evidence of their effectiveness.

"Detection of 92 percent of colon cancer is extremely high for a non-invasive test, so that a negative test result means that no further evaluation, like colonoscopy, is needed at that time," said Ransohoff. "Having such a sensitive, non-invasive option could have an important effect on screening rates for colorectal cancer."

While the DNA test appears to be more sensitive than the FIT test, it did produce more false positive results, which would lead to colonoscopy. Further, the study did not address the question of how frequently non-invasive testing might be needed.

Colorectal cancer is the third leading cause of cancer-related deaths in the United States and is expected to cause over 50,000 deaths in 2014, according to the American Cancer Society.

###

Visit link:

Genetic test could improve colon cancer screening

Miscarriage Clues Identified in New DNA Test According to Researchers at Montefiore and Einstein

Posted on by

Contact Information

Available for logged-in reporters only

Newswise NEW YORK (March 19, 2014) New research shows an alternative DNA test offers clinically relevant genetic information to identify why a miscarriage may have occurred years earlier. Researchers were able to identify chromosomal variants and abnormalities in nearly 50 percent of the samples. This first-of-its-kind study was conducted by researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University. The results were published in the March issue of Reproductive Biology and Endocrinology.

The technique used in this study, called rescue karyotyping, allows physicians to obtain important genetic information from tissue that had not been tested at the time of the miscarriage. As part of standard hospital protocol, tissue from miscarriages is embedded in paraffin for archival use and the karyotyping test is performed on DNA extracted from this tissue.

In this retrospective study of 20 samples from 17 women, genetic testing was successfully performed on 16 samples that had been archived for as long as four years. Of those samples, eight showed chromosomal variants and abnormalities. This is an important alternative when conventional karyotyping is not available or cannot be used for a specific sample.

Given the ease of obtaining results, even if a delay in testing occurs, this new test may provide a useful technique to gain a better understanding as to why miscarriage occurs in some women, said Zev Williams, M.D., Ph.D., director, Program for Early and Recurrent Pregnancy Loss (PEARL), Montefiore and Einstein, assistant professor of obstetrics & gynecology and womens health and of genetics at Einstein, and corresponding author of the study. I have seen women in tears because testing was not done at the time of the miscarriage and they feared they would never learn why it happened. Now we are able to go back and often get the answers we need.

One in five pregnancies ends in miscarriage, with the vast majority occurring in the first trimester. Recurrent miscarriage, which is defined as two or more miscarriages, occurs in up to 5 percent of couples attempting to conceive. Led by Dr. Williams, PEARL is comprised of a team of expert physicians, scientists, genetic counselors, nurses, technicians and staff members who work together to help these women maintain their pregnancies.

Montefiore and Einstein have worked together to develop an innovative model based on research, which allows us to develop novel diagnostic and treatment options and, in parallel, to quickly bring new advances to the clinic, said Dr. Williams. This represents a new and emerging model in medicine where the lab and clinic are brought closer in order to speed the pace of discovery and treatment.

Most miscarriages are caused by an abnormal number of chromosomes in the embryo, accounting for up to 75 percent of first trimester losses, continued Dr. Williams. This new test can help guide future treatment options but, importantly, can also help alleviate some of the guilt and self-blame often associated with unexplained miscarriage and can close a door or a painful chapter in a womans and couples life.

Dr. Williams is a board certified obstetrician gynecologist with specialty training in reproductive endocrinology and infertility. He received his M.D. and Ph.D. degrees from the Mount Sinai School of Medicine and trained in Obstetrics and Gynecology at Harvard Medical Schools Brigham and Womens Hospital and the Massachusetts General Hospital. Dr. Williams completed a fellowship in Reproductive Endocrinology and Infertility at Weill-Cornell Medical Center.

Read more:

Miscarriage Clues Identified in New DNA Test According to Researchers at Montefiore and Einstein

Internists must play a larger role in managing menopausal symptoms

Posted on by

PUBLIC RELEASE DATE:

19-Mar-2014

Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, March 19, 2014The number of menopausal women is projected to reach 50 million by 2020. With changing views on appropriate therapies to control symptoms and new treatments available and on the horizon, most internists lack the core competencies and experience to meet the needs of women entering menopause, according to a provocative Commentary published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Women's Health website at http://www.liebertpub.com/jwh.

The article "Competency in Menopause Management: Whither Goest the Internist?" by Richard Santen, MD, University of Virginia Health Sciences System (Charlottesville), Cynthia Stuenkel, MD, University of California at San Diego, Henry Burger, MD, Monash University (Melbourne, Australia), and JoAnn Manson, MD, Brigham and Women's Hospital, Harvard Medical School (Boston, MA), describes the changing landscape of menopausal symptom management, with renewed use of hormone therapy among recently menopausal women at low risk of breast cancer and heart disease. The emergence of new non-hormonal treatments and other approaches may be unfamiliar to internists who are often ill-prepared to manage symptoms in women who have completed their reproductive years and are approaching or beginning menopause.

"It is essential that new curricula be developed to train internists in the core competencies needed to manage menopausal symptoms," says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women's Health, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health.

###

About the Journal

Journal of Women's Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. The Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women's healthcare issues. Complete tables of content and a sample issue may be viewed on the Journal of Women's Health website at http://www.liebertpub.com/jwh. Journal of Women's Health is the official journal of the Academy of Women's Health and the Society for Women's Health Research.

About the Academy

Visit link:

Internists must play a larger role in managing menopausal symptoms

New DNA-editing technology spawns novel strategies for gene therapy

Posted on by

11 hours ago by Robert Sanders Human cardiac myocytes (muscle cells) stained green for proteins encoded by edited genes using the new CRISPR/Cas9 technology.

The University of California, Berkeley, and UC San Francisco are launching the Innovative Genomics Initiative (IGI) to lead a revolution in genetic engineering based on a new technology already generating novel strategies for gene therapy and the genetic study of disease.

The Li Ka Shing Foundation has provided a $10 million gift to support the initiative, establishing the Li Ka Shing Center for Genomic Engineering and an affiliated faculty chair at UC Berkeley. The two universities also will provide $2 million in start-up funds.

At the core of the initiative is a revolutionary technology discovered two years ago at UC Berkeley by Jennifer A. Doudna, executive director of the initiative and the new faculty chair. The technology, precision "DNA scissors" referred to as CRISPR/Cas9, has exploded in popularity since it was first published in June 2012 and is at the heart of at least three start-ups and several heavily-attended international meetings. Scientists have referred to it as the "holy grail" of genetic engineering and a "jaw-dropping" breakthrough in the fight against genetic disease. In honor of her discovery and earlier work on RNA, Doudna received last month the Lurie Prize of the Foundation for the National Institutes of Health.

"Professor Doudna's breakthrough discovery in genomic editing is leading us into a new era of possibilities that we could have never before imagined," said Li Ka-shing, chairman of the Li Ka Shing Foundation. "It is a great privilege for my foundation to engage with two world-class public institutions to launch the Innovative Genomics Initiative in this quest for the holy grail to fight genetic diseases."

In the 18 months since the discovery of this technology was announced, more than 125 papers have been published based on the technique. Worldwide, researchers are using Cas9 to investigate the genetic roots of problems as diverse as sickle cell anemia, diabetes, cystic fibrosis, AIDS and depression in hopes of finding new drug targets. Others are adapting the technology to reengineer yeast to produce biofuels and wheat to resist pests and drought.

"We now have a very easy, very fast and very efficient technique for rewriting the genome, which allows us to do experiments that have been impossible before," said Doudna, a professor of molecular and cell biology in the California Institute for Quantitative Biosciences (QB3) and an investigator in the Howard Hughes Medical Institute at UC Berkeley. "We are grateful to Mr. Li Ka-shing for his support of our initiative, which will propel ground-breaking advances in genomic engineering."

Transforming genetic research

The new genomic engineering technology significantly cuts down the time it takes researchers to test new therapies. CRISPR/Cas 9 allows the creation in weeks rather than years of animal strains that mimic a human disease, allowing researchers to test new therapies. The technique also makes it quick and easy to knock out genes in human cells or in animals to determine their function, which will speed the identification of new drug targets for diseases.

"The CRISPR/Cas9 technology is a complete game changer," said Jonathan Weissman, codirector of the initiative and professor of cellular and molecular pharmacology in the UCSF School of Medicine. "With CRISPR, we can now turn genes off or on at will. I am particularly interested in using CRISPR to understand the normal functions of genes as well as how disease-causing mutations alter these functions."

Visit link:

New DNA-editing technology spawns novel strategies for gene therapy

8 Bizarre Futurist Predictions That Never Came True

Posted on by

A rendering that depicts the future city of Liverpool.

By Rebecca Hiscott2014-03-19 10:06:59 UTC

Our visions of the future have always been more complex than hoverboards and self-lacing sneakers.

Sure, there were the various tropes from many bad sci-fi movies (and a few good ones), such as food in pill form, flying cars, personal jetpacks and robot butlers. But futurists also envisioned brave new worlds that have since been entirely forgotten the death of the letters C, X and Q, for example, not to mention the use of discarded underwear to manufacture candy (ew).

We doff our caps to Paleofuture for making these future-happy predictions from years hence so easily available. Below, we've resuscitated a few of our favorites, which have yet to come true.

"These prophecies will seem strange, almost impossible," begins a 1900 article in Ladies' Home Journal. "Yet they have come from the most conservative and learned minds in America."

These "learned minds" suggested that by the year 2000, certain letters of the alphabet would simply vanish: "There will be no C, X or Q in our every-day alphabet. They will be abandoned because unnecessary. Spelling by sound will have been adopted, first by the newspapers. English will be a language of condensed words expressing condensed ideas, and will be more extensively spoken than any other. Russian will be second."

In this French caricature called "Voyage a la lune" ("Journey to the moon"), a man rides a bicycle-like flying machine while looking through a telescope.

In 1909, Jules Bois, alternately referred to by The New York Times as a "mystic," a "litterateur" and a "Frenchman," rightly predicted that the era's ideal of feminine beauty would be overturned: "Physical weakness, extreme delicacy of physiognomy and acquiescence in a mere secondary position in the social organization will have given place to a type in which beauty and muscular development will be combined." (See: fitspo.)

See the rest here:

8 Bizarre Futurist Predictions That Never Came True

Featured Videos – Futurist.com: Futurist Speaker Glen Hiemstra

Posted on by

The Future. You have to see it to believe it.

On this page you will find recent videos of Glen speaking and being interviewed, videos that we produce, and other interesting videos about the future that I think are timely or worth highlighting in some way.

In this short film Glen Hiemstra, Founder of Futurist.com and of DoTheFuture.com, explores what it means to be a futurist and what drives his work. The film was produced by Graymatter Productions, Seattle, Washington. For more information contact info@futurist.com.

Glen Hiemstra, Founder and CEO of Futurist.com, takes us over the horizon into the world of the future. Are we ready to build a preferred future? Lets imagine that the issues of transparency, privacy, data security, openness and information ownership have been solved more or less satisfactorily by 2020.

Glen presents the future of transportation at the 8th Annual Texas Transportation Forum in Austin, TX. The panel discussion includes Co-Moderator Congressman Michael C. Burgess, and Michael E. Cline, Ph.D. from Rice University. More about the event can be found here: txdot.gov/ttf/.

In November 2011, Glen worked with Seattle photographer David Ryder to produce a new Keynote Sample Video with updated highlights and new commentary.

This is an excerpt from the Keynote speech Glen gave at Buhlers 150th anniversary celebration.

Children write postcards to the future the 50 year future in this charming video from ARC, used by permission.

We know that enough sunlight hits the earth every hour to power the worlds energy needs for a year. Someday, sooner than many think, earth civilization will be converting to solar energy. One of the most clever ideas for doing so is the solar road.

This podcast series includes insight from leading futurists Glen Hiemstra and Gerd Leonhard, who are interviewed by Mobile Entertainment Forum Chairman Emeritus and renowned music industry figure Ralph Simon. Produced by Doug Kaye (founder of the Conversations Network), the video series offers 11 podcasts covering a wide range of topics, including the future of communications, the future of entertainment, and Commercial versus Shared Culture.

View original post here:

Featured Videos - Futurist.com: Futurist Speaker Glen Hiemstra

Futurist Makes A Compelling Argument For Why We Should Bring Animals Back From Extinction

Posted on by

Last March, scientists met at a TEDx conference to discuss which extinct animals would be good candidates to bring back from the dead, called de-extinction.

One year later, futurist and environmentalist Stewart Brand appeared on Tuesday at a Ted conference in Vancouver to present the status of a few de-extinction projects.

At the paleogenomics lab at the University of California, Santa Cruz, for example, lab leader Beth Shapiro and a young scientist, Ben Novak, are trying to revive the first passenger pigeon by altering the DNA of the sally band-tailed pigeon, the passenger's closest genetic relative. A flock of band-tailed pigeons, Brand said, "is being groomed to become the first surrogate parents of passenger pigeons."

Keith Schengili-Roberts

The passenger pigeon went from numbering in the billions to being wiped out by the 19th century.

In another part of the world, Russian scientist Sergey Zimov has created a preserve in Siberia called Pleistocene Park that attempts to restore the type of grassland that existed when woolly mammoths called that place home. Zimov hopes to eventually re-introduce these hairy creatures to the environment.

While the thought of having herds of woolly mammoths running around doesn't immediately sound like a great idea, Brand makes a compelling case for why we should pursue the technique.

De-extinction is not just about reversing extinction, Brand says, but about helping to prevent extinction. It "could help revolutionize conservation," he said.

That's because de-extinction can be used to combat what's called the "extinction vortex" when animal populations fall, inbreeding becomes more common and species go extinct by loss of genetic variation. Endangered species like the black-footed ferret could potentially be saved by introducing old genes into current populations, Brand said.

Brand is the founder and former editor of the Whole Earth Catalog and the co-founder of the Long Now Foundation, an institution that supports projects that promote long-term thinking.

See the rest here:

Futurist Makes A Compelling Argument For Why We Should Bring Animals Back From Extinction

San Franciscos Hunters Point: A Wasteland Repaved

Posted on by

Candlestick Park is proof that San Francisco can get nostalgic about anything. A strange monument to a bygone peoples failed futurism, the former home of the Giants and 49ers is built of old-time patronage and reinforced concrete, located near an abandoned shipyard turned Superfund site. A few turns out of the stadium parking lot and youre in Bayview-Hunters Point, a long-neglected, predominantly black neighborhood where pollution from the Navys radiological lab and a local power plant have resulted in high rates of cancer and asthma. Candlestick was the backdrop to my childhood, says Kevin Epps, a local filmmaker who first documented the neighborhoods struggles in 2003s Straight Outta Hunters Point. But its like a one-sided relationship. The Niners got all the love, but in terms of opportunities for the community, there was none.

Isolated on the southeastern tip of San Francisco, the flatlands and repurposed barracks of Hunters Point were largely unaffected by the citys late-1990s boom, its Third Street artery dominated by liquor stores and shuttered windows. Epps began noticing changes along 3rd as he filmed his 2011 sequel. In 2007, the city linked the neighborhood to the rest of San Francisco with light-rail service, sprucing up Third with palm trees and public art. The first new grocery store in decades opened two years ago. It looks weird, Epps says. Its like some people are still trapped in time as the scenery is changing.

The thing about gentrification is how intuitive it appears in retrospecthow the answer was always nearby, as soon as that first person looked at a warehouse and saw somewhere to live. There are more bars, cafs, and young professionals, Epps jokes, from Boston and New York. Plans are under way here for the citys most ambitious redevelopment project since 1906, when an earthquake decimated San Francisco. Over the next decade, waterfront condos, retail space, and parks will go up where Candlestick once stood. The toxic and long-abandoned Hunters Point naval shipyard will finally be decontaminated and replaced by environmentally responsible development. Those who move into the 10,000 new mixed-income residential units will know this place by a new name: the San Francisco Shipyard.

San Francisco is too expensive for ruins. The last time I went to a 49er game, a friend showed me a shortcut to Candlestick. As we approached from the southwest, it felt like we were cutting through unmapped lands: fields of flagging reeds, a maze of dirt-lined back roads. It was like driving into the past. Even as the city had changed, tailgating before a Niner game still drew an eclectic multitude, from tech oligarchs perched on crates of wine to acid-casualty bikers to the melting pot of slangy young smokers. It felt like one of the last places in the city where the rich and the poor sat next to each other, everyone holding their phones to the sky in search of a signal.

Excerpt from:

San Franciscos Hunters Point: A Wasteland Repaved

Freedom Fighters of America, Video 46, Russia, Sanctions, Edwin Edwards, Malaysia Airlines – Video

Posted on by


Freedom Fighters of America, Video 46, Russia, Sanctions, Edwin Edwards, Malaysia Airlines
Freedom Fighters of America was born out of the lies and deceit of our elected officials, not just Democrats or Republicans, but all of them. We haven #39;t hear...

By: Lynn Cheramie

Originally posted here:

Freedom Fighters of America, Video 46, Russia, Sanctions, Edwin Edwards, Malaysia Airlines - Video

John Frost & his Souldiers – Rebel Soldiers Freedom Fighters (Official video) – Video

Posted on by


John Frost his Souldiers - Rebel Soldiers Freedom Fighters (Official video)
Official video of Rebel Soldiers Freedom Fighters Directed and produced by J. Nellestein Filmed by A. van Binsbergen R. Kersten Lyrics written by F. Schall...

By: John Frost and his Souldiers

See the original post:

John Frost & his Souldiers - Rebel Soldiers Freedom Fighters (Official video) - Video